Palisade Bio, Inc.
(NASDAQ: PALI)

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.

1.615 -

-0.055 (-3.29%)
Range 1.570 - 1.700   (8.28%)
Open 1.690
Previous Close 1.670
Bid Price 1.610
Bid Volume 5,001
Ask Price 1.620
Ask Volume 9,080
Volume 3,838,617
Value 4,376,817
Remark -
Delayed prices. Updated at 30 Jan 2026 01:35.
Data powered by
View All Events


Top Contributors

JonWick38 avatar
11428
Followers 273
Posts 2469

Loading Chart...

Please login to view stock data and analysis